Prescription to patenting: cannabis-derived medicinal products
von Dr Paul England
Cannabis: what's new for the 6000 year old medicine?
von Dr Paul England
Life Sciences Organisation sets out the UK stall
von Dr Paul England
Tailored injunctive relief in life sciences patent cases
von Dr Paul England
Biosimilars – interchangeability/substitution and advertising
von mehreren Autoren
SmPC 'carve out' limits marketing authorisation
Brexit and the life sciences sector: The UK Government's offer to the EU
von Dr Paul England
Brexit and the life sciences sector: what is the relevance of the transition (implementation) period?
von Dr Paul England
Brexit and the life sciences sector: guidelines for 'no deal'
von Matthew Royle, Ph.D. und Dr Paul England